The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 8,988 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 7,766 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| ADURO BIOTECH INC | COM | 00739L101 | 4,650 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 7,573 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 937 | 9,000 | SH | SOLE | 9,000 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 5,632 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 12,066 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 5,768 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 7,371 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 9,156 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 6,197 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 16,683 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 14,168 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 1,935 | 75,100 | SH | Call | SOLE | 75,100 | 0 | 0 | |
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 11,004 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 11,610 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 3,960 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| CONCERT PHARMACEUTICALS INC | COM | 206022105 | 8,015 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 1,315 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 2,307 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 9,082 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| ENDOCYTE INC | COM | 29269A102 | 19,998 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 11,280 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| CURRENCYSHARES SWISS FRANC T | SWISS FRANC SH | 23129V109 | 4,507 | 45,800 | SH | SOLE | 45,800 | 0 | 0 | ||
| GLYCOMIMETICS INC | COM | 38000Q102 | 4,058 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| G1 THERAPEUTICS INC | COM | 3621LQ109 | 5,558 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| IMMUNOGEN INC | COM | 45253H101 | 225 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 27,029 | 1,850,000 | SH | SOLE | 1,850,000 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 83,330 | 8,333 | SH | Put | SOLE | 8,333 | 0 | 0 | |
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 3,675 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 16,900 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 2,796 | 125,092 | SH | SOLE | 125,092 | 0 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 6,800 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,030 | 76,786 | SH | SOLE | 76,786 | 0 | 0 | ||
| LANNET INC | COM | 516012101 | 4,013 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 9,075 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| MOTUS GI HLDGS INC | COM | 62014P108 | 448 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 4,388 | 278,244 | SH | SOLE | 278,244 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,059 | 262,500 | SH | SOLE | 262,500 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 14,410 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 1,006 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 4,980 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| OBSEVA SA | COM | H5861P103 | 5,398 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 5,412 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 15,938 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 7,029 | 314,367 | SH | SOLE | 314,367 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 1,788 | 11,100 | SH | SOLE | 11,100 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E105 | 2,888 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 17,411 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 4,260 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 3,537 | 61,900 | SH | SOLE | 61,900 | 0 | 0 | ||
| VIEWRAY INC | COM | 92672L107 | 5,787 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 35,092 | 8,773 | SH | Put | SOLE | 8,773 | 0 | 0 | |